Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, CĂ´te d'Ivoire: a randomised trial
- 1 March 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 353  (9155) , 781-785
- https://doi.org/10.1016/s0140-6736(98)10412-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trialThe Lancet, 1999
- Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Côte d′IvoireAIDS, 1999
- Impact of zidovudine use on risk and risk factors for perinatal transmission of HIVAIDS, 1998
- Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus–1 transmission in FranceThe Journal of Pediatrics, 1997
- After AIDS Clinical Trial 076: The Changing Pattern of Zidovudine Use during Pregnancy, and the Subsequent Reduction in the Vertical Transmission of Human Immunodeficiency Virus in a Cohort of Infected Women and Their InfantsThe Journal of Infectious Diseases, 1996
- Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysisVirus Genes, 1996
- The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmissionAIDS, 1995
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Risk of human immunodeficiency virus type 1 transmission through breastfeedingThe Lancet, 1992
- Rapid and specific diagnosis of HIV-1 and HIV-2 infectionsAIDS, 1990